Clinical Trial

A Predictive Score for the Ischemic Etiology of a Transient Diplopia (VASCO-DIP)

Study acronym: VASCO-DIP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 25, 2025 (before its estimated September 23, 2025 completion). Its status may not reflect the trial's current state.
Summary
The transient diplopias (TD) is defined by a short diplopia. Their etiology may be ophthalmological, neurological non-ischemic or of ischemic origin. The difficulty is to recognize an ischemic mechanism which imposes emergency cares. A clinical score could help the clinician to recognize the etiology of the TD .
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2015-10-13; most recent amendment 2025-06-19.
Status change: Enrolling by Invitation → Recruiting 2019-03-22
Trial Details
NCT Number NCT02576925
Lead Sponsor Fondation Ophtalmologique Adolphe de Rothschild
Conditions Diplopia
Enrollment 220 participants
Start Date 2015-09-24
Primary Completion 2025-09-23 (estimated)
Study Completion 2025-12-23 (estimated)
Updated on ClinicalTrials.gov 2025-06-25